PUT - SPRINTER OPEN END - FRESENIUS MEDICAL CARE Share Price

Certificat

DE000VU94H17

Market Closed - Deutsche Boerse AG 11:21:50 27/05/2024 pm IST
20.21 EUR +0.95% Intraday chart for PUT - SPRINTER OPEN END - FRESENIUS MEDICAL CARE
Current month-1.99%
1 month-11.05%
Date Price Change
27/24/27 20.21 +0.95%
24/24/24 20.02 -3.80%
23/24/23 20.81 +2.41%
22/24/22 20.32 +4.80%
21/24/21 19.39 +4.53%

Delayed Quote Deutsche Boerse AG

Last update May 27, 2024 at 11:21 pm IST

More quotes

Static data

Product typeKnock-Out without Stop Loss
Buy / SellPUT
Underlying FRESENIUS MEDICAL CARE AG
IssuerLogo Issuer Vontobel Vontobel
WKN VU94H1
ISINDE000VU94H17
Date issued 19/07/2023
Strike 58.89
Maturity Unlimited
Parity 1 : 1
Emission price 12.07
Emission volume N/A
Settlement cash
Currency EUR

Technical Indicators

Highest since issue 28.92
Lowest since issue 10.48

Company Profile

Fresenius Medical Care AG, formerly Fresenius Medical Care AG & Co. KGaA is a Germany-based Company, which is a kidney dialysis institute. The Company provides dialysis care and related services to persons suffering from end-stage renal disease (ESRD), as well as other healthcare services. The Company also develops and manufactures a wide variety of health care products, which includes dialysis and non-dialysis products. Its dialysis products include hemodialysis machines, peritoneal cyclers, dialyzers, peritoneal solutions and granulates, bloodlines, renal pharmaceuticals and systems for water treatment. Its non-dialysis products include acute cardiopulmonary and apheresis products. The Company supplies dialysis clinics it owns, operates or manages with a broad range of products, and sells dialysis products to other dialysis service providers.
Sector
-
More about the company

Ratings for Fresenius Medical Care AG

Trading Rating
Investor Rating
ESG Refinitiv
A-
More Ratings

Consensus: Fresenius Medical Care AG

Sell
Consensus
Buy
Mean consensus
HOLD
Number of Analysts
19
Last Close Price
38.77 EUR
Average target price
39.84 EUR
Spread / Average Target
+2.77%
Consensus